College of Medicine

Medicine & Life Sciences

1. Taiwan 100%
2. Neoplasms 34%
3. Population 28%
4. Cohort Studies 26%
5. Apoptosis 25%
6. Therapeutics 25%
7. Meta-Analysis 25%
8. Stroke 24%
9. Confidence Intervals 22%
10. Proteins 19%
11. Systematic Reviews 16%
12. Genes 16%
13. Odds Ratio 15%
14. Randomized Controlled Trials 15%
15. Hepatocellular Carcinoma 15%
16. Neoplasm Metastasis 14%
17. Wounds and Injuries 14%
18. Lung 14%
19. Mortality 14%
20. Breast Neoplasms 14%
21. In Vitro Techniques 14%
22. Arsenic 14%
23. Chronic Renal Insufficiency 13%
24. Colorectal Neoplasms 13%
25. Kidney 13%
26. Inflammation 12%
27. Databases 12%
28. Down-Regulation 12%
29. Autophagy 12%
30. Growth 12%
31. Serum 12%
32. Reactive Oxygen Species 12%
33. Lipopolysaccharides 11%
34. Incidence 11%
35. Pharmaceutical Preparations 11%
36. Phosphorylation 10%
37. Endothelial Cells 10%
38. National Health Programs 10%
39. Macrophages 10%
40. Survival 10%
41. Blood Platelets 10%
42. Lung Neoplasms 10%
43. Biomarkers 10%
44. Gene Expression 10%
45. Atrial Fibrillation 10%
46. Brain 10%
47. Oxidative Stress 9%
48. MicroRNAs 9%
49. Glioblastoma 9%
50. Nitric Oxide 9%
51. Up-Regulation 9%
52. Cardiac Myocytes 9%
53. Liver 9%
54. Carcinoma 8%
55. Nanoparticles 8%
56. Messenger RNA 8%
57. Prostatic Neoplasms 8%
58. Renal Dialysis 8%
59. Retrospective Studies 8%
60. Antioxidants 8%
61. Pulmonary Veins 8%
62. Cell Proliferation 8%
63. Traumatic Brain Injury 8%
64. Cytokines 8%
65. Elderly 8%
66. Bipolar Disorder 8%
67. Child 8%
68. Glucose 8%
69. Mesenchymal Stem Cells 8%
70. Recurrence 8%
71. Cell Line 7%
72. Non-Small Cell Lung Carcinoma 7%
73. Infections 7%
74. ErbB Receptors 7%
75. Metabolic Syndrome 7%
76. Cell Movement 7%
77. Hypertension 7%
78. Pain 7%
79. Bone and Bones 7%
80. Calcium 7%
81. Heme Oxygenase-1 7%
82. Drug Therapy 7%
83. Exercise 7%
84. Control Groups 7%
85. Skin 7%
86. Parkinson Disease 7%
87. Schizophrenia 7%
88. Cell Death 7%
89. Logistic Models 7%
90. Blood Pressure 7%
91. Tuberculosis 7%
92. Type 2 Diabetes Mellitus 7%
93. Case-Control Studies 7%
94. Safety 7%
95. Stem Cells 7%
96. Fibrosis 7%
97. Neoplastic Stem Cells 6%
98. Glioma 6%
99. Dementia 6%
100. Quality of Life 6%